Alembic Pharmaceuticals Ltd. on Thursday, February 26, announced that it has received final approval from the US health regulator, the US Food and Drug Administration (USFDA), for its Abbreviated New ...
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine Orally Disintegrating Tablets USP, 25 mg, ...
Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic medication for seizures. The drug firm has received final approval from the US Food & ...
Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for antifungal drug Efinaconazole Topical Solution, ...
Drug firm Alembic Pharmaceuticals Ltd on Wednesday (February 18) completed an unannounced cGMP inspection by the United States Food and Drug Administration (USFDA) at its injectable facility (F-3) in ...
BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya ® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...
Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...